|
| MAGNESIUM DIPROPYLACETATE HYDRATE Basic information |
Product Name: | MAGNESIUM DIPROPYLACETATE HYDRATE | Synonyms: | Bis(2-propylpentanoic acid)magnesium salt;Einecs 263-770-9;Pentanoic acid, 2-propyl-, magnesium salt;MAGNESIUM DIPROPYLACETATE;MAGNESIUM DIPROPYLACETATE HYDRATE;MAGNESIUM VALPROATE;MAGNESIUM VALPROATE HYDRATE;2-propyl-pentanoicacimagnesiumsalt | CAS: | 62959-43-7 | MF: | C16H30MgO4 | MW: | 310.71 | EINECS: | 263-770-9 | Product Categories: | API | Mol File: | 62959-43-7.mol | ![MAGNESIUM DIPROPYLACETATE HYDRATE Structure](CAS/GIF/62959-43-7.gif) |
| MAGNESIUM DIPROPYLACETATE HYDRATE Chemical Properties |
Melting point | >294°C (dec.) | storage temp. | Refrigerator | solubility | Ethyl Acetate (Slightly), Methanol (Slightly), Water (Slightly) | form | Solid | color | White | CAS DataBase Reference | 62959-43-7 |
| MAGNESIUM DIPROPYLACETATE HYDRATE Usage And Synthesis |
Uses | Magnesium Valproate is an anticonvulsant agent and the effects it exerts are the result of valproic acid and magnesium acting in a complementary way. Magnesium valproate is effective as monotherapy in patients with newly diagnosed or previously treated partial or generalised epilepsy. | Uses | Antiepileptic | Trade name | Logical (Armstrong) | Safety Profile | Moderately toxic by
ingestion. Danger: A spontaneously
combustible solid. When heated to
decomposition it emits toxic vapors of
magnesium. | Synthesis |
Diethyl malonate is alkylated with 1-bromopropane and then hydrolyzed and decarboxylated to afford Magnesium valproate.
| Description | Valproic acid and its salt Magnesium Valproate is major antiepileptic drugs for the treatment of absence, myoclonic, and generalized tonic – clonic seizures and also may be effective against complex partial seizures. The most cited mechanisms are the increase in GABA function and the blockade of voltage-dependent Na+-channels. The most common side effects are gastrointestinal disturbances and sedation. The most serious adverse effect is liver damage, although this is rare. Teratogenic effects, predominantly spina bifida, are reported frequently. |
| MAGNESIUM DIPROPYLACETATE HYDRATE Preparation Products And Raw materials |
|